Clinical Trials Browser

OTHER × Interventional × Ranitidine × Clear all

Breast Carcinoma In Situ, Breast Neoplasms

NCT03145012 2023-02-08

Histamine Receptor 2 Antagonists as Enhancers of Anti-Tumour Immunity

Phase 4 Completed

30 enrolled

Tumor-Agnostic

Neoplasms

NCT05298683 2022-03-28

A Phase 2 Study of Isatuximab in Combination With Pomalidomide and Dexamethasone in MM Patients Who Received One Prior Line of Therapy Containing Lenalidomide and a Proteasome Inhibitor

Phase 2 Unknown

108 enrolled

Plasma cell

Blood Protein Disorders, Hematologic Diseases, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Renal Insufficiency, Neoplasms, Plasma Cell

NCT01332630 2018-09-20

TPI 287 in Breast Cancer Metastatic to the Brain

Phase 2 Completed

24 enrolled 8 charts

BreastCNS

Brain Neoplasms, Breast Neoplasms

Clinical Trials

Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel

Histamine Receptor 2 Antagonists as Enhancers of Anti-Tumour Immunity

A Phase 2 Study of Isatuximab in Combination With Pomalidomide and Dexamethasone in MM Patients Who Received One Prior Line of Therapy Containing Lenalidomide and a Proteasome Inhibitor

TPI 287 in Breast Cancer Metastatic to the Brain